Follow
Michael J Parnham
Michael J Parnham
Senior Advisor, EpiEndo Pharmaceuticals; Co-founder, Phialogics AG
Verified email at epiendo.com - Homepage
Title
Cited by
Cited by
Year
Azithromycin: mechanisms of action and their relevance for clinical applications
MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ...
Pharmacology & therapeutics 143 (2), 225-245, 2014
6742014
Nrf2, the master regulator of anti-oxidative responses
S Vomund, A Schäfer, MJ Parnham, B Brüne, A Von Knethen
International journal of molecular sciences 18 (12), 2772, 2017
5642017
Anti-inflammatory effects of macrolide antibiotics
O Čulić, V Eraković, MJ Parnham
European journal of pharmacology 429 (1-3), 209-229, 2001
4872001
Ebselen: prospective therapy for cerebral ischaemia
M Parnham, H Sies
Expert opinion on investigational drugs 9 (3), 607-619, 2000
3322000
Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects
O Čulić, V Eraković, I Čepelak, K Barišić, K Brajša, Ž Ferenčić, R Galović, ...
European journal of pharmacology 450 (3), 277-289, 2002
3262002
Pharmacology of synthetic organic selenium compounds
MJ Parnham, E Graf, VM Kolb, R Seth, S Sinha, RR Ruffolo, JP Hieble, ...
Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des …, 1991
2311991
Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions
MJ Parnham, E Graf
Biochemical pharmacology 36 (19), 3095-3102, 1987
2311987
The early research and development of ebselen
MJ Parnham, H Sies
Biochemical pharmacology 86 (9), 1248-1253, 2013
2282013
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
M Bosnar, Z Kelneric, V Munic, V Erakovic, MJ Parnham
Antimicrobial agents and chemotherapy 49 (6), 2372-2377, 2005
2122005
Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity
W Englberger, U Hadding, E Etschenberg, E Graf, S Leyck, J Winkelmann, ...
International journal of immunopharmacology 10 (6), 729-737, 1988
1951988
Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections
MJ Parnham
Current opinion in infectious diseases 18 (2), 125-131, 2005
1892005
A novel biologically active seleno-organic compound—III: effects of PZ 51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages
MJ Parnham, S Kindt
Biochemical pharmacology 33 (20), 3247-3250, 1984
1771984
Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression
VI Tkalčević, S Čužić, K Brajša, B Mildner, A Bokulić, K Šitum, D Perović, ...
European journal of pharmacology 570 (1-3), 212-221, 2007
1672007
Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections
H Sies, MJ Parnham
Free Radical Biology and Medicine 156, 107-112, 2020
1662020
Ceramides as novel disease biomarkers
J Kurz, MJ Parnham, G Geisslinger, S Schiffmann
Trends in molecular medicine 25 (1), 20-32, 2019
1662019
Prostaglandins and chronic inflammation
IL Bonta, MJ Parnham
Biochemical Pharmacology 27 (12), 1611-1623, 1978
1661978
Toxicity screening of liposomes
MJ Parnham, H Wetzig
Chemistry and physics of lipids 64 (1-3), 263-274, 1993
1641993
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro
H Shiratori, C Feinweber, S Luckhardt, B Linke, E Resch, G Geisslinger, ...
Molecular immunology 88, 58-68, 2017
1612017
Pharmacokinetics of non-intravenous formulations of fentanyl
J Lötsch, C Walter, MJ Parnham, BG Oertel, G Geisslinger
Clinical pharmacokinetics 52, 23-36, 2013
1552013
Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation
MJ Parnham
Phytomedicine 3 (1), 95-102, 1996
1471996
The system can't perform the operation now. Try again later.
Articles 1–20